Adaptimmune
Designing and delivering cell therapies to transform the lives of people with cancer.
200 employees · est. 2008 · Abingdon, United Kingdom
Legend Biotech
Multinational biopharmaceutical company focused on discovering and developing cutting-edge cell-based therapies
2565 employees · est. 2014 · Somerset, United States
Adaptimmune is the older company (2008 vs 2014); Legend Biotech is the larger of the two.
Side-by-Side Comparison
| Metric | Adaptimmune | Legend Biotech |
|---|---|---|
| Founded | ||
| Founded | 2008 older | 2014 |
| Headquarters | ||
| Headquarters | Abingdon, United Kingdom | Somerset, United States |
| Employees | ||
| Employees | 200 | 2565 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post Ipo Debt | Unknown |
| Total Funding | ||
| Total Funding | $499.50M | $1.62B |
| Funding Rounds | ||
| Funding Rounds | 9 | 4 |
| Services | ||
| Services | Development of T-cell therapies, Pipeline management of cell therapies, Sale and licensing of cell therapies, Biotechnological research, Clinical trials | End-to-end Cell Therapy Development, Drug Discovery, Clinical Trials, Commercialization of Therapies, Scientific Research and Publications |
| Target Customers | ||
| Target Customers | Cancer patients, Healthcare professionals, Biopharmaceutical companies, Medical researchers | Patients with Hematologic Malignancies, Patients with Solid Tumors, Healthcare Professionals, Oncologists, Biopharmaceutical Investors |
| Taxonomy | ||
| Taxonomy | Cell Therapy, Cancer Treatment, T Cell Therapies, Preclinical Research, Clinical Development, Translational Sciences, Autologous Manufacturing, Allogeneic Manufacturing, T Cell Receptor Proteins, Affinity T Cell Receptor, Immunotherapy, Infectious Disease Treatment, HIV Therapy, Corporate Operations | Biopharmaceutical, Cell-Based Therapies, Cell Therapy, Chimeric Antigen Receptor T-cell (CAR-T), Natural Killer (NK) Cell-based Immunotherapy, Oncology, Manufacturing Facilities, Clinical-Stage Therapeutics, R&D, Novel Therapies, Multiple Myeloma Treatment, Autologous Cell Therapy, Allogeneic Cell Therapy, Advanced Technology Platforms |
| Website | ||
| Website | adaptimmune.com | legendbiotech.com |
About Adaptimmune
Adaptimmune stands as a pioneering entity in the biopharmaceutical landscape, specializing in cell therapies designed to revolutionize cancer treatment. With its strong presence in four biotechnology hubs across the U.K. and U.S., the company showcases comprehensive competencies ranging from preclin...
About Legend Biotech
Legend Biotech, founded in 2014, is a rapidly advancing multinational biopharmaceutical company headquartered in the United States. The company is focused on discovering and developing cutting-edge cell-based therapies to address critical health needs. Operating across vital sectors like Biotechnolo...
We will tell you when either one moves
BounceWatch watches Adaptimmune and Legend Biotech for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Adaptimmune and Legend Biotech — by email.
Frequently Asked Questions
Compare Adaptimmune with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Adaptimmune on 11 Mar 2026, and Legend Biotech on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.